Post-Marketing Surveillance of Hepatitis A Virus Vaccine (Avaxim® 160U) in South Korea from 2011 to 2015

Overview of attention for article published in Infectious Diseases and Therapy, January 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

policy: 1 policy source

twitter: 4 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 11 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 9,840 followers.

RT @Arif_Koroglu69: @hakikatbilgisi 2011'den 2015'e kadar Güney Kore'de Hepatit A Virüsü Aşısının (Avaxim® 160U) Pazarlama Sonrası Gözetimi…

29 Dec 2023

Reply Repost Favourite

@hakikatbilgisi 2011'den 2015'e kadar Güney Kore'de Hepatit A Virüsü Aşısının (Avaxim® 160U) Pazarlama Sonrası Gözetimi.. Kaynak ; https://t.co/gOgvEk5XvS

29 Dec 2023

Reply Repost Favourite

Post-Marketing Surveillance of Hepatitis A Virus Vaccine (Avaxim® 160U) in South Korea from 2011 to 2015 https://t.co/SbNKcGg7aI Kim &al InfectDisTher

14 Feb 2019

Reply Repost Favourite

Post-Marketing Surveillance of #HepatitisA Virus #Vaccine (Avaxim® 160U) in South Korea from 2011 to 2015. Full article here: https://t.co/w2f17YASyA https://t.co/muWzsh51JS

23 Jan 2019

Reply Repost Favourite